High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer Organoids

New treatments are required for advanced prostate cancer; however, there are fewer preclinical models of prostate cancer than other common tumor types to test candidate therapeutics. One opportunity to increase the scope of preclinical studies is to grow tissue from patient-derived xenografts (PDXs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Choo, Nicholas, Ramm, Susanne, Luu, Jennii, Winter, Jean M., Selth, Luke A., Dwyer, Amy R., Frydenberg, Mark, Grummet, Jeremy, Sandhu, Shahneen, Hickey, Theresa E., Tilley, Wayne D., Taylor, Renea A., Risbridger, Gail P., Lawrence, Mitchell G., Simpson, Kaylene J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458687/
https://www.ncbi.nlm.nih.gov/pubmed/34111999
http://dx.doi.org/10.1177/24725552211020668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458687/
https://www.ncbi.nlm.nih.gov/pubmed/34111999
http://dx.doi.org/10.1177/24725552211020668

Ejemplares similares